Burden of Type 2 and Oral Corticosteroids Related Comorbidities in Severe Asthma Patients from the Gulf Countries: A Comparative Study from The ISAR Registry
Severe asthma patients in the Gulf showed a high prevalence of T2-related comorbidities and obesity, with fewer OCS-related conditions. These patterns vary by age, sex, and smoking, highlighting the need for personalized management in this region.
Authors
- Lakmini Bulathsinhala (ORCID: https://orcid.org/0009-0007-0466-4671)
- Riyad Al‐Lehebi (ORCID: https://orcid.org/0000-0002-3232-6668)
- G. Scelo
- Mona Al‐Ahmad (ORCID: https://orcid.org/0000-0003-2950-5363)
- Asmaa Ali
- Bassam Mahboub
- Aaron Beastall
- David Price
- Victoria Carter
- Dominic Friston
Institutions
- Jiangsu University (CN)
- Dubai Health Authority (AE)
- Alfaisal University (SA)
- University of Aberdeen (GB)
- Rashid Hospital (AE)
- King Fahd Medical City (SA)
- Kuwait University (KW)
- Observational & Pragmatic Research Institute (SG)
- Ministry of Health (KW)
Publication Details
- Journal
- Journal of Asthma and Allergy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/jaa.s555783
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Teva Pharmaceutical Industries
- Regeneron Pharmaceuticals
- Sanofi Genzyme
- Efficacy and Mechanism Evaluation Programme